PAPER Croce N, Ciotti MT, Gelfo F, Cortelli S, Federici G, Caltagirone C, Bernardini S, Angelucci F

Neuropeptide Y protects rat cortical neurons against β-amyloid toxicity and re-establishes synthesis and release of nerve growth factor.

ACS Chem Neurosci. 2012 Apr 18;3(4):312-8. PubMed.

PAPER Ono M, Watanabe H, Kimura H, Saji H

BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques.

ACS Chem Neurosci. 2012 Apr 18;3(4):319-24. PubMed.

PAPER Paranjape GS, Gouwens LK, Osborn DC, Nichols MR

Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia.

ACS Chem Neurosci. 2012 Apr 18;3(4):302-11. PubMed.

PAPER Kim HJ, Park JW, Byun JH, Poon WW, Cotman CW, Fowlkes CC, Jeon NL

Quantitative analysis of axonal transport by using compartmentalized and surface micropatterned culture of neurons.

ACS Chem Neurosci. 2012 Jun 20;3(6):433-8. PubMed.

PAPER Sinha S, Lopes DH, Bitan G

A Key Role for Lysine Residues in Amyloid β-Protein Folding, Assembly, and Toxicity.

ACS Chem Neurosci. 2012 Jun 20;3(6):473-81. PubMed.

PAPER Sinha S, Du Z, Maiti P, Klärner FG, Schrader T, Wang C, Bitan G

Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01.

ACS Chem Neurosci. 2012 Jun 20;3(6):451-8. PubMed.

PAPER Izuo N, Kume T, Sato M, Murakami K, Irie K, Izumi Y, Akaike A

Toxicity in Rat Primary Neurons through the Cellular Oxidative Stress Induced by the Turn Formation at Positions 22 and 23 of Aβ42.

ACS Chem Neurosci. 2012 Sep 19;3(9):674-81. PubMed.

PAPER Milton NG, Chilumuri A, Rocha-Ferreira E, Nercessian AN, Ashioti M

Kisspeptin Prevention of Amyloid-β Peptide Neurotoxicity in Vitro.

ACS Chem Neurosci. 2012 Sep 19;3(9):706-19. PubMed.

PAPER Abuznait AH, Kaddoumi A

Role of ABC transporters in the pathogenesis of Alzheimer's disease.

ACS Chem Neurosci. 2012 Nov 21;3(11):820-31. PubMed.

PAPER Fernández-Morales JC, Arranz-Tagarro JA, Calvo-Gallardo E, Maroto M, Padín JF, García AG

Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease.

ACS Chem Neurosci. 2012 Nov 21;3(11):873-83. PubMed.

PAPER Findeis MA, Schroeder F, McKee TD, Yager D, Fraering PC, Creaser SP, Austin WF, Clardy J, Wang R, Selkoe D, Eckman CB

Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa.

ACS Chem Neurosci. 2012 Nov 21;3(11):941-51. PubMed.

PAPER García-Osta A, Cuadrado-Tejedor M, García-Barroso C, Oyarzábal J, Franco R

Phosphodiesterases as therapeutic targets for Alzheimer's disease.

ACS Chem Neurosci. 2012 Nov 21;3(11):832-44. PubMed.

PAPER Gessel MM, Bernstein S, Kemper M, Teplow DB, Bowers MT

Familial Alzheimer's Disease Mutations Differentially Alter Amyloid β-Protein Oligomerization.

ACS Chem Neurosci. 2012 Nov 21;3(11):909-18. Epub 2012 Jun 26 PubMed.

PAPER Jameson LP, Smith NW, Dzyuba SV

Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly.

ACS Chem Neurosci. 2012 Nov 21;3(11):807-19. PubMed.

PAPER Lemkul JA, Bevan DR

The Role of Molecular Simulations in the Development of Inhibitors of Amyloid β-Peptide Aggregation for the Treatment of Alzheimer's Disease.

ACS Chem Neurosci. 2012 Nov 21;3(11):845-56. PubMed.